These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emerging role of capecitabine in gastric cancer. Comella P; Franco L; Casaretti R; de Portu S; Menditto E Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950 [TBL] [Abstract][Full Text] [Related]
6. [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal]. Macedo A; Pereira C; Gonçalves J; Sousa C Acta Med Port; 2009; 22(6):827-32. PubMed ID: 20350467 [TBL] [Abstract][Full Text] [Related]
7. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer. Iqbal S; Lenz HJ Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325 [TBL] [Abstract][Full Text] [Related]
8. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
10. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer. Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463 [TBL] [Abstract][Full Text] [Related]
11. Acute cardiotoxicity during capecitabine treatment: a case report. Bertolini A; Flumanò M; Fusco O; Muffatti A; Scarinci A; Pontiggia G; Scopelliti M Tumori; 2001; 87(3):200-6. PubMed ID: 11504378 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380 [TBL] [Abstract][Full Text] [Related]
16. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison. Saif MW Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249 [TBL] [Abstract][Full Text] [Related]
17. Capecitabine in the treatment of advanced gastric cancer. Lee JL; Kang YK Future Oncol; 2008 Apr; 4(2):179-98. PubMed ID: 18407732 [TBL] [Abstract][Full Text] [Related]
18. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer. Patel PA Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320 [TBL] [Abstract][Full Text] [Related]
19. ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. Gonzalez-Haba E; García MI; Cortejoso L; López-Lillo C; Barrueco N; García-Alfonso P; Alvarez S; Jiménez JL; Martín ML; Muñóz-Fernández MA; Sanjurjo M; López-Fernández LA Pharmacogenomics; 2010 Dec; 11(12):1715-23. PubMed ID: 21142915 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine in the management of colorectal cancer. Maroun JA Expert Rev Anticancer Ther; 2001 Oct; 1(3):327-33. PubMed ID: 12113099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]